Eiger BioPharmaceuticals on Monday announced that it has voluntarily filed for bankruptcy and has kicked off the process of selling its assets and winding down the company’s operations.
https://www.pharmalive.com/wp-content/uploads/2024/04/Biospacecourt4-1-2024.jpg350625BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2024-04-02 07:27:342024-04-02 09:58:19Eiger files for bankruptcy, plans to shutter operations after difficult year
